Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$3.24 USD
+0.09 (2.86%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $3.23 -0.01 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.91 |
EPS Last Quarter | -1.24 |
Last EPS Surprise | -49.40% |
ABR | 2.09 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.95 |
Next Year | -3.54 |
EPS (TTM) | -2.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 40.63M | NA |
# of Estimates | NA | NA | 7 | NA |
High Estimate | NA | NA | 41.00M | NA |
Low Estimate | NA | NA | 40.56M | NA |
Year ago Sales | 0.00M | 0.00M | NA | 40.63M |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.91 | -0.96 | -2.95 | -3.54 |
# of Estimates | 8 | 7 | 8 | 8 |
Most Recent Consensus | -0.91 | -0.94 | -2.95 | -3.50 |
High Estimate | -0.77 | -0.87 | -2.44 | -3.25 |
Low Estimate | -0.99 | -1.03 | -3.15 | -4.05 |
Year ago EPS | -0.79 | -0.83 | -4.47 | -2.95 |
Year over Year Growth Est. | -15.19% | -15.66% | 34.00% | -19.96% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 4 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.91 | -0.96 | -2.95 | -3.54 |
7 Days Ago | -0.91 | -0.96 | -2.95 | -3.54 |
30 Days Ago | -0.91 | -0.96 | -2.95 | -3.54 |
60 Days Ago | -0.85 | -0.90 | -2.72 | -3.60 |
90 Days Ago | -0.85 | -0.91 | -2.72 | -3.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.91 | -0.96 | -2.95 | -3.54 |
Zacks Consensus Estimate | -0.91 | -0.96 | -2.95 | -3.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.24 | 0.14 | -0.83 | -0.79 | NA |
Estimate | -0.83 | -0.85 | -0.92 | -1.01 | NA |
Difference | -0.41 | 0.99 | 0.09 | 0.22 | 0.22 |
Surprise | -49.40% | 116.47% | 9.78% | 21.78% | 24.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more